Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis
FranceStudy on Ganaxolone for Patients with Refractory Status Epilepticus
AustriaStudy on the Safety and Effectiveness of C1 Esterase Inhibitor and Sodium Chloride for Patients with Traumatic Brain Injury
The NetherlandsStudy of Suvecaltamide for Treating Moderate to Severe Tremor in Parkinson's Disease Patients
GermanyStudy on the Safety and Tolerability of Rugonersen in Patients with Angelman Syndrome
ItalyStudy on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination
FranceStudy on Gabapentin and Placebo for Short-Term Relief of Acute Lower Back Pain from Herniated Disc in Adults
FranceStudy on Lecanemab for Patients with Dominantly Inherited Alzheimer's Disease to Evaluate Prevention and Progression
FranceStudy on Cladribine for Treating Seropositive Myasthenia Gravis in Patients
PolandStudy of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma
FranceStudy on PRAX-628 for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications
ItalyStudy on Lutetium (177Lu) Zadavotide Guraxetan for Patients with Recurrent Grade 3 and Grade 4 Glioma
NorwayThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
